相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aptamer-Targeted Attenuation of IL-2 Signaling in CD8+ T Cells Enhances Antitumor Immunity
Anugraha Rajagopalan et al.
MOLECULAR THERAPY (2017)
Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB Costimulation
Brett Schrand et al.
CANCER RESEARCH (2017)
Targeting T Cell Co-receptors for Cancer Therapy
Margaret K. Callahan et al.
IMMUNITY (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
A Critical Role for Transcription Factor Smad4 in T Cell Function that Is Independent of Transforming Growth Factor β Receptor Signaling
Ai-Di Gu et al.
IMMUNITY (2015)
Reducing Toxicity of Immune Therapy Using Aptamer-Targeted Drug Delivery
Eli Gilboa et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
Alexey Berezhnoy et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
Brett Schrand et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
Jiehua Zhou et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Human CD1c+ Dendritic Cells Drive the Differentiation of CD103+ CD8+ Mucosal Effector T Cells via the Cytokine TGF-β
Chun I. Yu et al.
IMMUNITY (2013)
A daunting task: manipulating leukocyte function with RNAi
Dan Peer
IMMUNOLOGICAL REVIEWS (2013)
Truncated Form of TGF-βRII, But Not Its Absence, Induces Memory CD8+ T Cell Expansion and Lymphoproliferative Disorder in Mice
Harumichi Ishigame et al.
JOURNAL OF IMMUNOLOGY (2013)
Excessive Th1 responses due to the absence of TGF-β signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis
Harumichi Ishigame et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Current progress on aptamer-targeted oligonucleotide therapeutics
Justin P. Dassie et al.
THERAPEUTIC DELIVERY (2013)
TGF-β and αvβ6 Integrin Act in a Common Pathway to Suppress Pancreatic Cancer Progression
Aram F. Hezel et al.
CANCER RESEARCH (2012)
Molecular Pathways: Targeting the TGF-β Pathway for Cancer Therapy
Anna L. Smith et al.
CLINICAL CANCER RESEARCH (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Wnt5a Potentiates TGF-β Signaling to Promote Colonic Crypt Regeneration After Tissue Injury
Hiroyuki Miyoshi et al.
SCIENCE (2012)
Thermal Stability of siRNA Modulates Aptamer-conjugated siRNA Inhibition
Alexey Berezhnoy et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Improving cancer immunotherapy by targeting tumor-induced immune suppression
Trina J. Stewart et al.
CANCER AND METASTASIS REVIEWS (2011)
Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term TβRI/II Kinase Inhibition with LY2109761
Erin C. Connolly et al.
CANCER RESEARCH (2011)
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
Moses K. Donkor et al.
IMMUNITY (2011)
Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts
Xiaohua Ni et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras
Lee Adam Wheeler et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
Fernando Pastor et al.
MOLECULAR THERAPY (2011)
An Aptamer-siRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4+ T Cell Decline in Humanized Mice
Charles Preston Neff et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Transforming growth factor-beta: A target for cancer therapy
Ronan J. Kelly et al.
JOURNAL OF IMMUNOTOXICOLOGY (2010)
Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
Fernando Pastor et al.
NATURE (2010)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression
Li Yang et al.
TRENDS IN IMMUNOLOGY (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
TGFβ signalling: a complex web in cancer progression
Hiroaki Ikushima et al.
NATURE REVIEWS CANCER (2010)
Companies Waver in Efforts To Target Transforming Growth Factor β in Cancer
Ken Garber
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P. Dassie et al.
NATURE BIOTECHNOLOGY (2009)
Transforming Growth Factor β: Tumor Suppressor or Promoter? Are Host Immune Cells the Answer?
Li Yang et al.
CANCER RESEARCH (2008)
Overcoming the innate immune response to small interfering RNA
Adam Judge et al.
HUMAN GENE THERAPY (2008)
TGFβ signalling in control of T-cell-mediated self-reactivity
Yuri P. Rubtsov et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
YA Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
L Gorelik et al.
IMMUNITY (2000)
分享论文
